Perspective of antiviral therapeutics for hepatitis C after liver transplantation

doi:10.5497/wjp.v3.i4.193

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8008)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

344

WORD

278

HTML

2329

Figures (1-2)

212

Tables (1-1)

220

Sum=3383

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

703

Download

1427

Sum=2130

Publishing Process of This Article

Item

Count

Browse

1211

Download

1284

Sum=2495

Dec 9, 2014 (publication date) through Jan 26, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Therapeutics Advances

World J Pharmacol. Dec 9, 2014; 3(4): 193-198
Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.193

Full Size Figure Download Figure

Figure 1 Post-transplant course of a liver recipient with hepatitis C recurrence.

Citation: Ho CM, Hu RH, Lee PH. Perspective of antiviral therapeutics for hepatitis C after liver transplantation. World J Pharmacol 2014; 3(4): 193-198
URL: https://www.wjgnet.com/2220-3192/full/v3/i4/193.htm
DOI: https://dx.doi.org/10.5497/wjp.v3.i4.193